Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-08 | Amended | $2,860,000 | Unknown | Equity and Debt | SEC link | |
| 2025-08-06 | New | $2,832,000 | $2,832,000 | Equity and Debt | 06b | SEC link |
| 2023-11-29 | New | $999,998 | $999,998 | Equity Only | 06b | SEC link |
| 2022-12-29 | New | $5,976,217 | $5,976,217 | Equity Only | 06b | SEC link |
| 2020-12-11 | New | $40,245 | $40,245 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Wayne Embree | Director |
| Bethany George | Director |
| Samuel Lee | Director |
| Robert Shalwitz | Director, Executive |
| Michael Venerable | Director |
| Faith Voinovich | Director |
| Tim Willis | Director |
| Rachael Wingo | Executive |